Back to discover
Drug

Misoprostol

Approved medicine
ClassProstanoid EP3 receptor agonistResearchOngoing clinical research

Also known as Arthrotec, Cytotec, Misoprostolum.

11
Active clinical trials
PTGER3
Primary target
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Cervical Ripening Balloon Compared With Vaginal Misoprostol for Cervical Ripening in Obese Woman at Term

Clinical trial2026-07-06Results expected Q4 2026 · ClinicalTrials.gov

Foley Balloon for Cervical Preparation Before Dilation and Evacuation

Clinical trial2026-04-30Results expected Q1 2027 · ClinicalTrials.gov

Misoprostol to Optimizing Prevention of Cancer of the Cervix: A Double-Blind Randomized Controlled Trial

Clinical trial2025-10-01Results expected Q4 2026 · ClinicalTrials.gov

Rectal Misoprostol as a Hemostatic Agent During Abdominal Myomectomy

Clinical trial2025-07-29Results posted · ClinicalTrials.gov

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Misoprostol
Aliases & brands
ArthrotecCytotecMisoprostolum
RxNorm CUI
42331
ChEMBL ID
CHEMBL606
ATC codes
G02AD06A02BB01
UNII
0E43V0BB57
Primary mechanism
Prostanoid EP3 receptor agonist

Pharmacology & targets

1 target

Known molecular targets and mechanisms supported by curated pharmacology databases.

AGONISTProstanoid EP3 receptor agonist

Clinical trials

190 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
190
registered trials across all phases
LATEST COMPLETION 2025
11
Active studies
8
Recruiting
160
Late-stage (III+)
113
Completed
66
Discontinued
PHASE DISTRIBUTIONn = 190
Early Phase 16Phase 15Phase 219Phase 2 / 313Phase 330Phase 446Phase N / A71

Late-stage studies

Phase III+ trials still open or recently active — where late-stage evidence is being generated.

Recent completions

Trials that read out recently, adding to the completed evidence base.

References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • ClinicalTrials.gov — clinical trials